Skip to main content
Clinical Trials/CTRI/2023/09/057225
CTRI/2023/09/057225
Not yet recruiting
Phase 2

Assessing The Efficacy of Individualised Homoeopathic Medicines Selected Through Synthetic Repertory in Treatment of Insomnia: A Single-Blind Randomized Placebo-Controlled Clinical Trial. - NI

axmiben Homoeopathy Institute and Research Center0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: G470- Insomnia
Sponsor
axmiben Homoeopathy Institute and Research Center
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
axmiben Homoeopathy Institute and Research Center

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects who have been diagnosed as per the DSM\-V Diagnostic Criteria for Insomnia.
  • 2\.Subjects will be selected irrespective of their sex, socio\-economic status, and occupation.
  • 3\.Age between 18 to 50 years.
  • 4\.If the subject is illiterate then the relatives or family members will be assessed to fill the sleep diary.
  • 5\.Subjects who are willing to participate and sign the written informed consent form.

Exclusion Criteria

  • 1\.Subjects suffering from the complications of insomnia.
  • 2\.Subjects are undergoing treatment with non\-steroidal anti\-inflammatory drugs (NSAIDs), antiemetics, triptans, ergot alkaloids, and estrogen for 2 weeks prior to enrollment in the study.
  • 3\.Subjects suffering from uncontrolled systemic illness or psychiatric diseases and/or life\-threatening infections.
  • 4\.Substance abuse and/or dependence.
  • 5\.Pregnant or lactating women.
  • 6\.Subjects already undergoing homoeopathic treatment elsewhere for any chronic disease within the last 02 months.
  • 7\.Non\-compliance to the study treatment/ protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials